Skip to main content

Second annual stem cell symposium to focus on heart tissue, blood diseases

April 9, 2007

Several of the world’s leading experts on the formation of blood and heart cells from stem cells, and clinical applications of stem cells in blood and heart diseases, will come together on Wednesday, April 18, for the second annual Wisconsin Stem Cell Symposium.

Coordinated by the University of Wisconsin–Madison/NIH Stem Cell Training Program, the UW Stem Cell and Regenerative Medicine Center and the BioPharmaceutical Technology Center Institute (BCTI), the conference’s confirmed keynote speakers include:

— Piero Anversa, New York Medical College

— Connie J. Eaves, Terry Fox Laboratory, BC Cancer Research Centre, Vancouver, Canada

— Timothy J. Kamp, UW–Madison

— Gordon M. Keller, Ontario Cancer Institute, Toronto, Canada

— Douglas W. Losordo, The Feinberg School of Medicine, Northwestern University

— Christine L. Mummery, Hubrecht Laboratory, University Medical Center, Utrecht, The Netherlands

— Stuart H. Orkin, Children’s Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard University

— Igor I. Slukvin, UW–Madison

The Wisconsin Stem Cell Symposium will be held at Promega Corporation’s BioPharmaceutical Technology Center (BTC) at 5445 E. Cheryl Parkway, Fitchburg. The center is also home to the BTCI, the educational nonprofit that Promega supports.

“With such an impressive collection of thought leaders from the stem cell field, there are real possibilities for new thinking and new discovery. We are proud to sponsor such rich opportunities for science,” says Bill Linton, CEO of Promega and president of the BTCI Board of Directors.

The Wisconsin Stem Cell Symposium is open to the public and registration is $60.

For more information, including links to the symposium’s brochure and online registration, contact BTCI at (608) 273-9737.